Balyasny Asset Management’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $783K | Buy |
+135,647
| New | +$783K | ﹤0.01% | 1449 |
|
|
2025
Q1 | – | Sell |
-16,485
| Closed | -$144K | – | 2231 |
|
|
2024
Q4 | $144K | Sell |
16,485
-17,312
| -51% | -$151K | ﹤0.01% | 1782 |
|
|
2024
Q3 | $660K | Buy |
+33,797
| New | +$660K | ﹤0.01% | 1459 |
|
|
2024
Q1 | – | Sell |
-25,527
| Closed | -$367K | – | 2230 |
|
|
2023
Q4 | $367K | Sell |
25,527
-21,338
| -46% | -$307K | ﹤0.01% | 1546 |
|
|
2023
Q3 | $427K | Buy |
+46,865
| New | +$427K | ﹤0.01% | 1352 |
|
|
2023
Q2 | – | Sell |
-1,146,056
| Closed | -$14M | – | 2100 |
|
|
2023
Q1 | $14M | Sell |
1,146,056
-1,152,963
| -50% | -$14.1M | 0.04% | 515 |
|
|
2022
Q4 | $28.5M | Buy |
2,299,019
+407,534
| +22% | +$5.06M | 0.08% | 270 |
|
|
2022
Q3 | $25.8M | Buy |
1,891,485
+457,471
| +32% | +$6.25M | 0.08% | 278 |
|
|
2022
Q2 | $26.3M | Buy |
+1,434,014
| New | +$26.3M | 0.09% | 271 |
|